|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 31/335 | (2006.01) |
| (11) | Number of the document | 2114367 |
| (13) | Kind of document | T |
| (96) | European patent application number | 07750153.4 |
| Date of filing the European patent application | 2007-02-07 | |
| (97) | Date of publication of the European application | 2009-11-11 |
| (45) | Date of publication and mention of the grant of the patent | 2015-11-04 |
| (46) | Date of publication of the claims translation | 2016-01-25 |
| (86) | Number | PCT/US2007/003285 |
| Date | 2007-02-07 |
| (87) | Number | WO 2008/097220 |
| Date | 2008-08-14 |
| (72) |
SINGH, Onkar, N., US
WALL, G., Michael, US
JANI, Rajni, US
CHOWHAN, Masood, A., US
HAN, Wesley, Wehsin, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Olopatadino kompozicijos vietiniam įvedimui per nosį |
| OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION |
| Payment date | Validity (years) | Amount | |
| 2026-01-20 | 20 | 347.00 EUR |